Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study
Go back to Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study| (NASDAQ: EDSA) | Delayed: 4.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.97 | 52 Week High | $ | |||
| Open | $4.97 | 52 Week Low | $ | |||
| Day High | $4.97 | P/E | N/A | |||
| Day Low | $4.97 | EPS | $ | |||
| Volume | 55 | |||||

